The drug aprotinin inhibits entry of SARS-CoV2 in host cells

The surface of the SARS-CoV-2 virus is studded with spike proteins. The virus needs these in order to dock onto proteins (ACE2 receptors) on the surface of the host cell. Before this docking is possible, parts of the spike protein have to be cleaved by the host cell's enzymes - proteases.

Source: World Pharma News - November 23, 2020 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news